Cite

HARVARD Citation

    Kim, S. et al. (2018). Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients. Annals of oncology. pp. 1037-1048. [Online]. 
  
Back to record